Compare Heron Therapeutics Inc (HRTX) vs Rush Street Interactive Inc (RSI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Rush Street Interactive Inc — how do they compare? Heron Therapeutics Inc trades at $0.38 (market cap $68.01M), while Rush Street Interactive Inc trades at $19.5 (market cap $2.35B). The key difference: Rush Street Interactive Inc is far larger — about 34.6× Heron Therapeutics Inc's market cap, and Rush Street Interactive Inc is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and Rush Street Interactive Inc for 13 Days on average.
| HRTX | RSI | |
|---|---|---|
Market Cap | $68.01M | $2.35B |
Volume | 1,891,941 | 2,219,374 |
Sector | Health | Consumer Cyclical |
52-Week High | $1.49 | $34.52 |
52-Week Low | $0.27 | $15.89 |
Typical Hold Time | 35 Days | 13 Days |
Enterprise Value | $174.75M | $2.01B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Heron Therapeutics (HRTX) trades at $0.39, up 0.95% with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7M but missed EPS estimates with a $0.03 loss. Despite negative profitability metrics, analyst consensus remains strongly positive with 89% buy ratings. Recent news highlights ongoing comparisons with peers and earnings discussions.
The outlook remains challenged by persistent losses and negative margins, though strong analyst support suggests potential upside. Key risks include execution on sales targets and achieving profitability. The stock's low price near 52-week lows presents speculative opportunity but requires careful risk management given financial performance.
RSI trades at $19.89, down 1.73% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported Q2 2026 EPS of $0.15, beating estimates, and revenue growth to $1.4 billion projected for 2026. Analyst consensus is strongly bullish with a $34.88 price target, though net income margins remain thin at 2.33%.
The stock presents a mixed outlook: strong analyst support and revenue growth contrast with high valuation multiples and bearish technical trends. Key risks include competitive pressures in online gaming and reliance on sports betting cycles. Upside depends on margin improvement and execution of growth initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Rush Street Interactive Inc
Rush Street Interactive, Inc. is a digital gaming and sports betting company operating in the regulated U.S. and international markets. The company owns and operates online casino (iGaming) and sports wagering platforms, including BetRivers and PlaySugarHouse brands. RSI focuses on providing a secure and high-quality online gaming experience, leveraging its proprietary technology platform and commitment to responsible gaming.
Read more on RSI →
